A Retrospective Evaluation of Eribulin Dosing Schedules in Metastatic Breast Cancer

Class of 2016 Abstract === Objectives: To determine the number of patients treated with eribulin who required an alternate dosing schedule other than “day 1/day 8” due to side effects. Methods: Chart reviews were conducted on all patients who met inclusion criteria. Data collected included patient...

Full description

Bibliographic Details
Main Authors: Gagliardo, Camille, Lybeck, Megan, Bowles, Harmony
Language:en_US
Published: The University of Arizona. 2016
Subjects:
Online Access:http://hdl.handle.net/10150/613986
http://arizona.openrepository.com/arizona/handle/10150/613986